IRIS Accounts Production v24.3.2.46 08982814 director 1.10.23 30.9.24 30.9.24 0 0 true false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh089828142023-09-30089828142024-09-30089828142023-10-012024-09-30089828142022-09-30089828142022-10-012023-09-30089828142023-09-3008982814ns15:EnglandWales2023-10-012024-09-3008982814ns14:PoundSterling2023-10-012024-09-3008982814ns10:Director12023-10-012024-09-3008982814ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3008982814ns10:SmallEntities2023-10-012024-09-3008982814ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3008982814ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3008982814ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3008982814ns10:FullAccounts2023-10-012024-09-3008982814ns10:CompanySecretary12023-10-012024-09-3008982814ns10:RegisteredOffice2023-10-012024-09-3008982814ns5:CurrentFinancialInstruments2024-09-3008982814ns5:CurrentFinancialInstruments2023-09-3008982814ns5:ShareCapital2024-09-3008982814ns5:ShareCapital2023-09-3008982814ns5:CapitalRedemptionReserve2024-09-3008982814ns5:CapitalRedemptionReserve2023-09-3008982814ns5:RetainedEarningsAccumulatedLosses2024-09-3008982814ns5:RetainedEarningsAccumulatedLosses2023-09-3008982814ns5:CostValuation2023-09-3008982814ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3008982814ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-30
REGISTERED NUMBER: 08982814 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 September 2024

for

GSK Holdings Ltd

GSK Holdings Ltd (Registered number: 08982814)






Contents of the Financial Statements
for the year ended 30 September 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


GSK Holdings Ltd

Company Information
for the year ended 30 September 2024







DIRECTOR: G Abbey





SECRETARY:





REGISTERED OFFICE: Paces Campus
Pack Horse Lane
High Green
Sheffield
South Yorkshire
S35 3HY





REGISTERED NUMBER: 08982814 (England and Wales)





ACCOUNTANTS: Royston Parkin Limited
2 President Buildings
Savile Street East
Sheffield
South Yorkshire
S4 7UQ

GSK Holdings Ltd (Registered number: 08982814)

Statement of Financial Position
30 September 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Investments 4 2 2

CURRENT ASSETS
Debtors 5 1,218 968,858
Cash at bank 218,269 2,500,624
219,487 3,469,482
CREDITORS
Amounts falling due within one year 6 5,491 222,662
NET CURRENT ASSETS 213,996 3,246,820
TOTAL ASSETS LESS CURRENT
LIABILITIES

213,998

3,246,822

CAPITAL AND RESERVES
Called up share capital - 2
Capital redemption reserve 2 -
Retained earnings 213,996 3,246,820
SHAREHOLDERS' FUNDS 213,998 3,246,822

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

GSK Holdings Ltd (Registered number: 08982814)

Statement of Financial Position - continued
30 September 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 December 2024 and were signed by:





G Abbey - Director


GSK Holdings Ltd (Registered number: 08982814)

Notes to the Financial Statements
for the year ended 30 September 2024

1. STATUTORY INFORMATION

GSK Holdings Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

GSK Holdings Ltd (Registered number: 08982814)

Notes to the Financial Statements - continued
for the year ended 30 September 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 October 2023
and 30 September 2024 2
NET BOOK VALUE
At 30 September 2024 2
At 30 September 2023 2

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 1,218 968,858

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors - 2,119
Amounts owed to participating interests 2,041 2,041
Taxation and social security 1,950 -
Other creditors 1,500 218,502
5,491 222,662

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

All loans are given to/from Directors interest free with no fixed repayment terms.

8. ULTIMATE CONTROLLING PARTY

The company was under the joint control of Mr M Abbey and Mrs M E Abbey who together own a 90% share of the company's share capital up until the 23rd April 2024. From this date onwards the company is under the control of Mr G M Abbey who owns 100% on the share capital of the company..